Werkgroep Cardiologische centra Nederland

OMNEON (Completed)

A Phase IIb, Randomized, Placebo-Controlled, Dose-Range Finding Clinical Trial to Study the Safety and Efficacy of MK-3102 in Patients With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control
Medicine
MK-3102
Population
Diabetes mellitus
Phase
IIb
Starting year
2010
More information
ClinicalTrials.gov

Contact

dr. J. Schaap (Cardioloog)
Breda, Amphia Ziekenhuis